Author:
Amaral Murilo S.,Maciel Lucas F.,Silveira Gilbert O.,Olberg Giovanna G. O.,Leite João V. P.,Imamura Lucas K.,Pereira Adriana S. A.,Miyasato Patricia A.,Nakano Eliana,Verjovski-Almeida Sergio
Abstract
AbstractSchistosoma mansoni is a flatworm that causes schistosomiasis, a neglected tropical disease that affects more than 200 million people worldwide. There is only one drug indicated for treatment, praziquantel, which may lead to parasite resistance emergence. The ribonucleoside analogue 5-azacytidine (5-AzaC) is an epigenetic drug that inhibits S. mansoni oviposition and ovarian development through interference with parasite transcription, translation and stem cell activities. Therefore, studying the downstream pathways affected by 5-AzaC in S. mansoni may contribute to the discovery of new drug targets. Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides with low or no protein coding potential that have been involved in reproduction, stem cell maintenance and drug resistance. We have recently published a catalog of lncRNAs expressed in S. mansoni life-cycle stages, tissues and single cells. However, it remains largely unknown if lncRNAs are responsive to epigenetic drugs in parasites. Here, we show by RNA-Seq re-analyses that hundreds of lncRNAs are differentially expressed after in vitro 5-AzaC treatment of S. mansoni females, including intergenic, antisense and sense lncRNAs. Many of these lncRNAs belong to co-expression network modules related to male metabolism and are also differentially expressed in unpaired compared with paired females and ovaries. Half of these lncRNAs possess histone marks at their genomic loci, indicating regulation by histone modification. Among a selected set of 8 lncRNAs, half of them were validated by RT-qPCR as differentially expressed in females, and some of them also in males. Interestingly, these lncRNAs are also expressed in other life-cycle stages. This study demonstrates that many lncRNAs potentially involved with S. mansoni reproductive biology are modulated by 5-AzaC and sheds light on the relevance of exploring lncRNAs in response to drug treatments in parasites.
Funder
Fundação Butantan
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Springer Science and Business Media LLC
Reference122 articles.
1. WHO. Global Health Estimates 2016: Disease Burden by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva, World Health Organization.2016. https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html Accessed Jan 2020. (2016).
2. Mutapi, F., Maizels, R., Fenwick, A. & Woolhouse, M. Human schistosomiasis in the post mass drug administration era. Lancet Infect. Dis. 17, e42–e48. https://doi.org/10.1016/S1473-3099(16)30475-3 (2017).
3. Wilson, R. A. Schistosomiasis then and now: What has changed in the last 100 years?. Parasitology 147, 507–515. https://doi.org/10.1017/S0031182020000049 (2020).
4. Colley, D. G., Bustinduy, A. L., Secor, W. E. & King, C. H. Human schistosomiasis. Lancet 383, 2253–2264. https://doi.org/10.1016/S0140-6736(13)61949-2 (2014).
5. Zoni, A. C., Catala, L. & Ault, S. K. Schistosomiasis prevalence and intensity of infection in Latin America and the Caribbean Countries, 1942–2014: A systematic review in the context of a regional elimination goal. PLoS Negl. Trop. Dis. 10, e0004493. https://doi.org/10.1371/journal.pntd.0004493 (2016).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献